Latest News

Testing Parkinson's disease immune-based drugs: New models

Using powerful, newly developed cell culture and mouse models of sporadic Parkinson?s disease (PD), researchers have demonstrated that immunotherapy with specifically targeted antibodies may block the development and spread of PD pathology in the brain. By intercepting the distorted and misfolded alpha-synuclein (?-syn) proteins that enter and propagate in neurons, creating aggregates, the researchers prevented the development of pathology and also reversed some of the effects of already-existing disease.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • How to stop a stroke in its tracks

  • Significant increase in major depression reported during recent recession

  • Discovery may open door for treating fragile X carriers

  • Fat tissue controls brain's response to food scarcity, helping regulate optimal amount of body fat for brain function

  • Risk perception: Social exchange can amplify subjective fears

  • Psychology of the appeal of being anti-GMO

  • New light shed on brain's source of power

  • We think better on our feet, literally

  • Inclusive classrooms don't necessarily increase friendships for children with disabilities

  • New insight into how brain makes memories

  •